The United Nations General Assembly could turn the tide on antimicrobial resistance. The keys to making this happen are ensuring policymakers have the best available evidence and rallying political support through unifying goals.
Later this month, world leaders, civil society and global health researchers like me will convene at the UN General Assembly for arguably the most important meeting on antimicrobial resistance (AMR) this decade. On Sept. 26, a special high-level meeting on AMR will set the global agenda to mobilize action on this growing health and development challenge.
The stakes are high. AMR is a complex global challenge that — like climate change — no one country can deal with alone. AMR occurs when the bacteria and other microbes that cause infections like pneumonia, sepsis or tuberculosis gain the ability to resist treatment by antibiotics or other antimicrobial medicines. These drug-resistant microbes are sometimes called “superbugs.”
